Cargando…
Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis
Totally implantable vascular access devices (TIVADs) are often used to administer chemotherapy by prolonged intravenous infusion. The objective of the present study was to investigate the incidence of long-term complications and identify risk factors associated with TIVAD placement in patients with...
Autores principales: | Okazaki, Mitsuyoshi, Oyama, Katsunobu, Kinoshita, Jun, Miyashita, Tomoharu, Tajima, Hidehiro, Takamura, Hiroyuki, Ninomiya, Itasu, Fushida, Sachio, Ohta, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713938/ https://www.ncbi.nlm.nih.gov/pubmed/31475061 http://dx.doi.org/10.3892/mco.2019.1897 |
Ejemplares similares
-
Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
por: Kurata, Toru, et al.
Publicado: (2018) -
Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2017) -
The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2018) -
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study
por: Saito, Hiroto, et al.
Publicado: (2017) -
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
por: Ohbatake, Yoshinao, et al.
Publicado: (2015)